Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Cash from Investing Activities (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Cash from Investing Activities for 12 consecutive years, with $250000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cash from Investing Activities fell 94.62% year-over-year to $250000.0, compared with a TTM value of $3.3 million through Sep 2025, down 33.08%, and an annual FY2024 reading of $7.3 million, up 269.01% over the prior year.
  • Cash from Investing Activities was $250000.0 for Q2 2025 at Arcadia Biosciences, down from $500000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $17.4 million in Q2 2021 and bottomed at -$4.7 million in Q2 2023.
  • Average Cash from Investing Activities over 5 years is $1.2 million, with a median of $215000.0 recorded in 2024.
  • The sharpest move saw Cash from Investing Activities crashed 9925.0% in 2023, then soared 12400.0% in 2025.
  • Year by year, Cash from Investing Activities stood at -$70000.0 in 2021, then soared by 501.43% to $281000.0 in 2022, then plummeted by 81.49% to $52000.0 in 2023, then surged by 4736.54% to $2.5 million in 2024, then crashed by 90.06% to $250000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for RKDA at $250000.0 in Q2 2025, $500000.0 in Q1 2025, and $2.5 million in Q4 2024.